
Targeted Metallo-Drugs
Design, Development, and Modes of Action
- 370 pages
- English
- ePUB (mobile friendly)
- Available on iOS & Android
Targeted Metallo-Drugs
Design, Development, and Modes of Action
About this book
Volume 24, entitled Targeted Metallo-Drugs: Design, Development, and Modes of Action, of the series Metal Ions in Life Sciences (MILS), fosters inter-disciplinary research in the vibrant field of Biological Inorganic Chemistry. Inspired by the clinical success of cisplatin as a leading anticancer drug but mindful of the shortcomings associated with its use including dose-limiting toxic side effects and acquired or intrinsic drug resistance, scientists across the globe have been endeavoring to identify new metallo-drugs for therapeutic exploitation. This has led to innovative metallo-drug candidates that (i) enhance cancer cell selectivity, thus reducing toxic side effects, and/or (ii) possess new modes of action to improve efficacy and also target resistance pathways. This and more are captured in MILS- 24 which consists of 12 comprehensive, well-illustrated, and up to date chapters with over 1600 citations, 100 figures, and 10 tables with key contributions from 32 international experts from Europe, Asia, and North and South America. MILS- 24 not only keeps the scientific community abreast of latest developments, it also serves as an invaluable resource to stimulate further research on targeted metallo-drug design and development.
- It covers anticancer, antimicrobial, antiviral, and other agents, such as those targeting tropical diseases and cyanide poisoning and radiometals in molecular imaging and therapy
- It highlights recent metallo-drug developments targeting COVID-19
- It features advanced spectroscopic methods and metallomics as important tools to elucidate the modes of actions of metallo-drugs
Frequently asked questions
- Essential is ideal for learners and professionals who enjoy exploring a wide range of subjects. Access the Essential Library with 800,000+ trusted titles and best-sellers across business, personal growth, and the humanities. Includes unlimited reading time and Standard Read Aloud voice.
- Complete: Perfect for advanced learners and researchers needing full, unrestricted access. Unlock 1.4M+ books across hundreds of subjects, including academic and specialized titles. The Complete Plan also includes advanced features like Premium Read Aloud and Research Assistant.
Please note we cannot support devices running on iOS 13 and Android 7 or earlier. Learn more about using the app.
Information
Table of contents
- Cover
- Title Page
- Copyright Page
- About the Editors
- Historical Development and Perspectives of the Series
- Preface to Volume 24
- Table of Contents
- Contributors to Volume 24
- Handbooks and Book Series Published and (Co-)edited by the SIGELs
- Chapter 1 Metal-Based Prodrugs Activated by Cancer-Specific Stimuli
- Chapter 2 Light-Activated Drugs for Photodynamic and Photoactivated Therapy
- Chapter 3 Mitochondria as a Metallo-Drug Target for Therapeutic Purposes
- Chapter 4 Transition Metal-Based Antiviral Agents Against SARS-CoV-2 and Other Pathogenic Viruses
- Chapter 5 Exploiting the Chemical Diversity of Metal Compounds as a Source of Novel Anti-COVID-19 Drugs
- Chapter 6 Evaluating the Potential of Novel Metal-Based Drugs for Treating Drug-Resistant Bacteria
- Chapter 7 Prospective Metallo-Drugs Including Bioactive Compounds Selection of Co-Ligands to Tune Biological Activity Against Neglected Tropical Diseases
- Chapter 8 Challenges in Targeting Cyanide Poisoning: Advantages in Exploiting Metal Complexes in Its Treatment
- Chapter 9 Advanced Microscopy Methods for Elucidating the Localization of Metal Complexes in Cancer Cells
- Chapter 10 Metalloproteomics: A Powerful Technique for Metals in Medicine
- Chapter 11 Metal-Based Nanoclusters for Biomedical Applications
- Chapter 12 Radiometals in Molecular Imaging and Therapy
- Index